{"id":20167,"date":"2025-10-26T18:18:24","date_gmt":"2025-10-26T17:18:24","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=20167"},"modified":"2026-01-11T18:07:26","modified_gmt":"2026-01-11T17:07:26","slug":"prioritizing-health-human-rights-and-sustainable-development-in-drug-policies","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2025\/10\/prioritizing-health-human-rights-and-sustainable-development-in-drug-policies\/","title":{"rendered":"Prioritizing health, human rights, and sustainable development in drug policies"},"content":{"rendered":"<p><main role=\"main\"><\/p>\n<div class=\"layout-content\">\n<div id=\"block-mainpagecontent\" data-block-plugin-id=\"system_main_block\">\n<article>\n<div class=\"coh-container article-page\"><main class=\"coh-inline-element ssa-component coh-component ssa-component-instance-4166138f-0c7a-46a9-8e7d-267d3f9c4d5f coh-component-instance-4166138f-0c7a-46a9-8e7d-267d3f9c4d5f article-deepdive overflow-hidden fluid grid-container mt-h\"><\/p>\n<section class=\"coh-container ssa-component coh-component ssa-component-instance-4166138f-0c7a-46a9-8e7d-267d3f9c4d5f coh-component-instance-4166138f-0c7a-46a9-8e7d-267d3f9c4d5f article-headings scroll-track inviewport\" data-viewport=\"true\">\n<div class=\"coh-container grid-x overflow-hidden\">\n<div class=\"coh-container cell small-12 large-9 large-offset-1\">\n<h2 class=\"coh-heading article-title\"><span style=\"font-size: 16px;\">Statement by Marcos Neto, UN Assistant Secretary-General, and Director of UNDP\u2019s Bureau for Policy and Programme Support, at the launch of the third UNDP Discussion Paper on drug policy and development, &#8216;Development Dimensions of Drug Policy: New Challenges, Opportunities, and Emerging Issues&#8217;.\u00a0<\/span><span style=\"font-size: 12pt;\">September 17, 2025<\/span><\/h2>\n<\/div>\n<\/div>\n<\/section>\n<div>\n<figure class=\"coh-inline-element ssa-component coh-component ssa-component-instance-7d5f2506-e5a6-44b8-8778-0f37b228914d coh-component-instance-7d5f2506-e5a6-44b8-8778-0f37b228914d wide\"><\/figure>\n<div class=\"coh-container ssa-component coh-component ssa-component-instance-9e36029d-db7c-4a6b-a31c-85c363a6db88 coh-component-instance-9e36029d-db7c-4a6b-a31c-85c363a6db88 article-authors yellow coh-style-author-card-section\">\n<div class=\"coh-row coh-row-xl coh-row-visible-xl\" data-coh-row-match-heights=\"{&quot;xl&quot;:{&quot;target&quot;:&quot;none&quot;}}\">\n<div class=\"coh-row-inner coh-style-margin-x-0\">\n<div class=\"coh-column author-section coh-visible-xs coh-col-xs-12 coh-col-xs-offset-0 coh-visible-sm coh-col-sm-10 coh-col-sm-offset-2 coh-visible-lg coh-col-lg-7 coh-col-lg-offset-2 coh-visible-xl coh-col-xl-7 coh-col-xl-offset-2\">\n<div class=\"coh-row coh-row-xl coh-row-visible-xl\" data-coh-row-match-heights=\"{&quot;xl&quot;:{&quot;target&quot;:&quot;none&quot;}}\">\n<div class=\"coh-row-inner\">\n<div class=\"coh-col-xs-12 coh-col-sm-12 coh-col-lg-12 coh-col-xl-12\"><\/div>\n<div class=\"coh-col-xs-12 coh-col-sm-12 coh-col-lg-12 coh-col-xl-12  author-box\">\n<div class=\"author-label\">\n<p>&nbsp;<\/p>\n<p>Good afternoon, distinguished colleagues and friends.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"coh-container ssa-component coh-component ssa-component-instance-0ac4a943-3be0-4177-ba48-fd2da381dba4 coh-component-instance-0ac4a943-3be0-4177-ba48-fd2da381dba4  coh-style-padding-top-bottom-large ssa-instance-2f65847f1f5de9bab68223a8d8cf0e0c coh-ce-cpt_row_for_columns-5f467588\">\n<div class=\"coh-container \">\n<div class=\"coh-row coh-row-xl coh-row-visible-xl\" data-coh-row-match-heights=\"{&quot;xl&quot;:{&quot;target&quot;:&quot;none&quot;}}\">\n<div class=\"coh-row-inner yellow ssa-instance-2f65847f1f5de9bab68223a8d8cf0e0c coh-ce-cpt_row_for_columns-544cba20\">\n<div class=\"coh-column ssa-component coh-component ssa-component-instance-02de40eb-1aec-4d6e-946e-165d7050b0c9 coh-component-instance-02de40eb-1aec-4d6e-946e-165d7050b0c9  coh-ce-cpt_column-9431213c coh-visible-xs coh-col-xs-12 coh-col-xs-push-0 coh-col-xs-pull-0 coh-col-xs-offset-0 coh-visible-sm coh-col-sm-7 coh-visible-xl coh-col-xl-7\">\n<div class=\"coh-wysiwyg ssa-component coh-component ssa-component-instance-b1ef83f6-c4c9-4869-8fb0-b36d5a9f378a coh-component-instance-b1ef83f6-c4c9-4869-8fb0-b36d5a9f378a\">\n<p>Welcome to the side event\u00a0<a href=\"https:\/\/www.undp.org\/publications\/development-dimensions-drug-policy-assessing-new-challenges-uncovering-opportunities-and-addressing-emerging-issues\"><strong>Development Dimensions of Drug Policy: Exploring New Challenges, Opportunities, and Emerging Issues.<\/strong><\/a><\/p>\n<p>This is an important conversation. Drug policy remains one of the least represented issues in the 2030 Agenda and the Sustainable Development Goals. The SDGs mention drugs only in the context of substance abuse &#8211; a narrow framing.<\/p>\n<p>In reality, the global illicit drug economy, estimated at more than 600 billion dollars, has profound implications for health, human rights, livelihoods, security, the environment, and development. For decades, punitive responses associated with the so-called \u201cwar on drugs\u201d have dominated, often with devastating consequences for individuals, families, communities, and entire economies.<\/p>\n<p>Today, we benefit from a growing body of evidence that demonstrates the far-reaching impacts of drug policies. We know that both production and control measures carry serious environmental costs. We know that the proliferation of new substances poses complex public health challenges. And we know that punitive approaches have led to severe human rights violations.<\/p>\n<p>Since the adoption of the 2030 Agenda, UNDP has worked to broaden the understanding of drug policy, extending beyond the security frame, to a development frame with significant human and health impacts. UNDP works on rights and access to services for key HIV populations, including people who use drugs, in 97 countries. Through its partnership with the Global Fund, UNDP has supported HIV programmes in 57 countries, reaching 86,245 people who use drugs with essential services. We work to deliver the UN System Common Position on Drugs, that calls on us to work through partnerships grounded in human rights, health, and science.<\/p>\n<p>And I am pleased that today we launch the third paper in UNDP\u2019s series on the development dimensions of drug policy.<\/p>\n<p>This new paper addresses today\u2019s increasingly complex landscape:<\/p>\n<ul>\n<li>the rise of synthetic drugs,<\/li>\n<li>the diversification of drug markets,<\/li>\n<li>the emergence of regulated cannabis and psychedelics frameworks and the risks of their \u201ccorporate capture,\u201d<\/li>\n<li>as well as the growing effects of drug production and control on climate and biodiversity.<\/li>\n<\/ul>\n<p>The paper also proposes a way forward, highlighting innovative, pragmatic, and people-centered approaches that are evidence- and rights-based.<\/p>\n<p>These approaches prioritize health, human rights, and sustainable development. They ensure meaningful community participation and remove legal barriers to prevention, treatment, care, and support services, making sure that we leave no one behind.<\/p>\n<p>While there is still a lot of work to be done, around the world Member States &#8211; including my home country, Brazil &#8211; are showing that it is possible to safeguard human rights, respect minorities and Indigenous peoples, address the disproportionate impacts on women and youth, and deliver better health and development outcomes for people who use drugs.<\/p>\n<p>We hope today\u2019s conversation will inspire many more.<\/p>\n<p>It is now my great honour to introduce His Excellency Ernesto Zedillo, Commissioner of the Global Commission on Drug Policy, distinguished scholar, and former President of Mexico.<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"coh-container ssa-component coh-component ssa-component-instance-ca46ae3f-40f7-45ee-b42c-ccf16ef820ab coh-component-instance-ca46ae3f-40f7-45ee-b42c-ccf16ef820ab   ssa-instance-3ac329b41f4b9c19547c417462c76bd4 coh-ce-cpt_row_for_columns-5f467588\">\n<div class=\"coh-container \">\n<div class=\"coh-row coh-row-xl coh-row-visible-xl\" data-coh-row-match-heights=\"{&quot;xl&quot;:{&quot;target&quot;:&quot;none&quot;}}\">\n<div class=\"coh-row-inner yellow ssa-instance-3ac329b41f4b9c19547c417462c76bd4 coh-ce-cpt_row_for_columns-544cba20\">\n<div class=\"coh-column ssa-component coh-component ssa-component-instance-b6072be2-acb8-44d7-b2b7-62bb79af35ec coh-component-instance-b6072be2-acb8-44d7-b2b7-62bb79af35ec  coh-ce-cpt_column-9431213c coh-visible-xs coh-col-xs-12 coh-col-xs-push-0 coh-col-xs-pull-0 coh-col-xs-offset-0 coh-visible-sm coh-col-sm-9 coh-visible-xl coh-col-xl-9\">\n<section class=\"coh-container ssa-component coh-component ssa-component-instance-1740c39d-1728-4920-b141-4a3b7c26eec0 coh-component-instance-1740c39d-1728-4920-b141-4a3b7c26eec0\">\n<div class=\"coh-container  blockq\"><strong>Presentation by Commissioner Zedillo:<\/strong><\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><\/main><\/div>\n<\/article>\n<\/div>\n<div id=\"block-undpsolrsearch\" data-block-plugin-id=\"undp_solr_search_block\">\n<h2 class=\"coh-heading\">Development Dimensions of Drug Policy: Assessing New Challenges, Uncovering Opportunities, and Addressing Emerging Issues &#8211;\u00a0September 16, 2025<\/h2>\n<p class=\"coh-paragraph margin-top-36\">\n<div class=\"coh-container coh-wysiwyg\">\n<div>\n<p>This discussion paper examines how drug policy affects sustainable development, human rights, governance, health, and the environment. It underscores that punitive enforcement has largely failed, fueling violence, corruption, incarceration, and health crises, while doing little to reduce harm. In response, many countries are shifting toward evidence- and rights-based reforms such as decriminalization and harm reduction. Yet, organized crime continues to dominate markets, and debates over legal regulation are expanding.<\/p>\n<p>The paper highlights both the opportunities and risks of regulation. It shows how reforms could redirect resources into health and social programmes, strengthen governance, and support sustainable livelihoods, particularly for marginalized communities. At the same time, it warns of inequities in emerging legal markets, &#8220;corporate capture&#8221;, and insufficient attention to gender, Indigenous rights, and environmental impacts.<\/p>\n<p>Aimed at decision- and policy-makers, multilateral organizations, scholars, and civil society, the paper calls for a development-oriented, rights-based approach that ensures no one is left behind and aligns drug policy with the Sustainable Development Goals. It is the third paper of the series on drug policy and development produced by UNDP.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"country-switcher-ajax-wrapper\"><\/div>\n<\/div>\n<p><\/main><\/p>\n<footer class=\"footer\" role=\"contentinfo\">\n<footer class=\"footer\">\n<div class=\"grid-x\">\n<div class=\"cell medium-10 medium-offset-1\">\n<div class=\"grid-x footer-head\">\n<div class=\"cell large-5 cell-12\">\n<div class=\"footer-logo\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/footer>\n<\/footer>\n","protected":false},"excerpt":{"rendered":"<p>Statement by Marcos Neto, UN Assistant Secretary-General, and Director of UNDP\u2019s Bureau for Policy and Programme Support, at the launch of the third UNDP Discussion Paper on drug policy and development, &#8216;Development Dimensions of Drug Policy: New Challenges, Opportunities, and Emerging Issues&#8217;.\u00a0September 17, 2025 &nbsp; Good afternoon, distinguished colleagues and friends. Welcome to the side [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20,139],"tags":[],"class_list":["post-20167","post","type-post","status-publish","format-standard","hentry","category-others","category-strategy-and-policy"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/20167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=20167"}],"version-history":[{"count":1,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/20167\/revisions"}],"predecessor-version":[{"id":20168,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/20167\/revisions\/20168"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=20167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=20167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=20167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}